Keswani Sanjay 4
4 · Annexon, Inc. · Filed Mar 26, 2021
Insider Transaction Report
Form 4
Annexon, Inc.ANNX
Keswani Sanjay Chandru
EVP & Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-03-24−3,995→ 182,956 totalExercise: $7.49Exp: 2029-06-20→ Common Stock (3,995 underlying) - Exercise/Conversion
Common Stock
2021-03-24$7.49/sh+3,995$29,917→ 3,995 total - Sale
Common Stock
2021-03-24$30.17/sh−3,995$120,512→ 0 total
Footnotes (3)
- [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades in prices ranging from $30.00 to $30.49, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]25% of the shares subject to the option vest on the first anniversary measured from June 17, 2019 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.